Answer
Emtricitabine/tenofovir disoproxil may be considered during pregnancy if necessary, as data from more than 1,000 pregnancy outcomes indicate no associated malformations or foetal/neonatal toxicity and animal studies indicate no reproductive toxicity.
Sources for this answer
- Emtricitabine/Tenofovir Disoproxil 200 mg/245 mg Film-coated TabletsViatris (formerly Mylan or Upjohn) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked